This document discusses computer aided formulation development and optimization techniques. It provides an introduction to using computer tools for optimization of formulation and processing parameters. Optimization involves choosing the best alternative by making the formulation as perfect, functional, and effective as possible based on specific conditions. The document discusses factors, levels, responses, and response surfaces in optimization. It explains that optimization is a regulatory requirement for justification and defense of a formulation during inspections. Various experimental designs used in optimization include factorial designs, fractional factorial designs, central composite designs, and Box-Behnken designs. Design of experiments is useful for process optimization and validation in formulation development of different dosage forms.
INDIAN REGULATORY REQUIREMENTS FOR LABELING OF COSMETICSPV. Viji
INDIAN REGULATORY REQUIREMENTS FOR LABELING OF COSMETICS , IMPORTANCE OF LABELING , LABELING REQUIREMENTS , Common or generic name of the product. , Product function , Use instruction , Name & address of Manufacturer , Country of manufacture , Manufacture Date , Expiry date , Net Quantity , Retail Sale Price , Storage condition , Barcodes , Batch number , Warning or Caution if hazard exists , Manufacturing License Number , Ingredients , Registration Certificate Number (RCN) , Consumer Care Details , Using Stickers , Brown/Red or green dot , Not a standard pack size under Legal Metrology(Packaged commodities) Rules
Statistical modeling in pharmaceutical research and developmentPV. Viji
Statistical modeling in pharmaceutical research and development , Statistical Modeling , Descriptive Versus Mechanistic Modeling , Statistical Parameters Estimation , Confidence Regions , Non Linearity at the Optimum , Sensitivity Analysis , Optimal Design , Population Modeling
The release of the drug substance from the drug product leading to the bioavailability of the drug substance. The assessment of drug product performance is imp. Since bioavailability is related both to the pharmacodynamic responses and the adverse events. The performance tests relate the quality of a drug product to clinical safety and efficacy.
Bioavailability studies are drug product performance studies used to define
the effect of changes in the physicochemical properties of the drug substance, the formulation of the drug, and the manufacturing process of the drug product.
REGULATORY AND INDUSTRY VIEWS ON QbD, SCIENTIFICALLY BASED QbD- EXAMPLES OF A...Ardra Krishna
The pharmaceutical Quantity by Design (QbD) is a systemic approach to development that begins with predefined objectives and emphasizes product and process understanding and process control, based on sound science and quantity risk management.
QbD has been adopted by U.S Food and Drug Administration (FDA) for the discovery, development and manufacture of drugs.
Quality- by- design (QbD) is a concept introduces by the International Conference on Harmonization (ICH) Q8 guidelines.
An in-vitro in-vivo correlation (IVIVC) has been defined by the U.S. Food and Drug Administration (FDA) as "a predictive mathematical model describing the relationship between an in-vitro property of a dosage form and an in-vivo response".
Optimization technique is a rational approach for selecting the excipients, their concentrations and process conditions for obtaining the best possible product satisfying the quality characteristics.
Optimization is an act, process or methodology of making design, system or decisions as fully perfect, functional or as effective as possible.
INDIAN REGULATORY REQUIREMENTS FOR LABELING OF COSMETICSPV. Viji
INDIAN REGULATORY REQUIREMENTS FOR LABELING OF COSMETICS , IMPORTANCE OF LABELING , LABELING REQUIREMENTS , Common or generic name of the product. , Product function , Use instruction , Name & address of Manufacturer , Country of manufacture , Manufacture Date , Expiry date , Net Quantity , Retail Sale Price , Storage condition , Barcodes , Batch number , Warning or Caution if hazard exists , Manufacturing License Number , Ingredients , Registration Certificate Number (RCN) , Consumer Care Details , Using Stickers , Brown/Red or green dot , Not a standard pack size under Legal Metrology(Packaged commodities) Rules
Statistical modeling in pharmaceutical research and developmentPV. Viji
Statistical modeling in pharmaceutical research and development , Statistical Modeling , Descriptive Versus Mechanistic Modeling , Statistical Parameters Estimation , Confidence Regions , Non Linearity at the Optimum , Sensitivity Analysis , Optimal Design , Population Modeling
The release of the drug substance from the drug product leading to the bioavailability of the drug substance. The assessment of drug product performance is imp. Since bioavailability is related both to the pharmacodynamic responses and the adverse events. The performance tests relate the quality of a drug product to clinical safety and efficacy.
Bioavailability studies are drug product performance studies used to define
the effect of changes in the physicochemical properties of the drug substance, the formulation of the drug, and the manufacturing process of the drug product.
REGULATORY AND INDUSTRY VIEWS ON QbD, SCIENTIFICALLY BASED QbD- EXAMPLES OF A...Ardra Krishna
The pharmaceutical Quantity by Design (QbD) is a systemic approach to development that begins with predefined objectives and emphasizes product and process understanding and process control, based on sound science and quantity risk management.
QbD has been adopted by U.S Food and Drug Administration (FDA) for the discovery, development and manufacture of drugs.
Quality- by- design (QbD) is a concept introduces by the International Conference on Harmonization (ICH) Q8 guidelines.
An in-vitro in-vivo correlation (IVIVC) has been defined by the U.S. Food and Drug Administration (FDA) as "a predictive mathematical model describing the relationship between an in-vitro property of a dosage form and an in-vivo response".
Optimization technique is a rational approach for selecting the excipients, their concentrations and process conditions for obtaining the best possible product satisfying the quality characteristics.
Optimization is an act, process or methodology of making design, system or decisions as fully perfect, functional or as effective as possible.
Design of experiments formulation development exploring the best practices ...Maher Al absi
Now days computer tools used in the formulation and development of pharmaceutical product. Various technique such as design of experiment are implemented for optimization of formulation and processing parameter.
Software Used In Formulation Design Process (Pharmaceutics).PdfRAHUL PAL
This is an Minor project of mine, to explaining the Various software which are generally used in the designing for drug dosage form .
This project gave me more of the knowledge about drug designing.
In which lots of software are considered as Formulation.
Helping for PHARMACEUTICS, PHARMACEUTICAL ANALYSIS student. And some of articles review.
It's data are from standard as well as notebook.
computer aided formulation and development(How to use design expert software)Roshan Bodhe
computer aided formulation and development
optimization in formulation and development
How to use design expert software in formulation and development
ARTIFICIAL INTELLIGENCE IN HEALTHCARE.pdfAnujkumaranit
Artificial intelligence (AI) refers to the simulation of human intelligence processes by machines, especially computer systems. It encompasses tasks such as learning, reasoning, problem-solving, perception, and language understanding. AI technologies are revolutionizing various fields, from healthcare to finance, by enabling machines to perform tasks that typically require human intelligence.
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...Oleg Kshivets
RESULTS: Overall life span (LS) was 2252.1±1742.5 days and cumulative 5-year survival (5YS) reached 73.2%, 10 years – 64.8%, 20 years – 42.5%. 513 LCP lived more than 5 years (LS=3124.6±1525.6 days), 148 LCP – more than 10 years (LS=5054.4±1504.1 days).199 LCP died because of LC (LS=562.7±374.5 days). 5YS of LCP after bi/lobectomies was significantly superior in comparison with LCP after pneumonectomies (78.1% vs.63.7%, P=0.00001 by log-rank test). AT significantly improved 5YS (66.3% vs. 34.8%) (P=0.00000 by log-rank test) only for LCP with N1-2. Cox modeling displayed that 5YS of LCP significantly depended on: phase transition (PT) early-invasive LC in terms of synergetics, PT N0—N12, cell ratio factors (ratio between cancer cells- CC and blood cells subpopulations), G1-3, histology, glucose, AT, blood cell circuit, prothrombin index, heparin tolerance, recalcification time (P=0.000-0.038). Neural networks, genetic algorithm selection and bootstrap simulation revealed relationships between 5YS and PT early-invasive LC (rank=1), PT N0—N12 (rank=2), thrombocytes/CC (3), erythrocytes/CC (4), eosinophils/CC (5), healthy cells/CC (6), lymphocytes/CC (7), segmented neutrophils/CC (8), stick neutrophils/CC (9), monocytes/CC (10); leucocytes/CC (11). Correct prediction of 5YS was 100% by neural networks computing (area under ROC curve=1.0; error=0.0).
CONCLUSIONS: 5YS of LCP after radical procedures significantly depended on: 1) PT early-invasive cancer; 2) PT N0--N12; 3) cell ratio factors; 4) blood cell circuit; 5) biochemical factors; 6) hemostasis system; 7) AT; 8) LC characteristics; 9) LC cell dynamics; 10) surgery type: lobectomy/pneumonectomy; 11) anthropometric data. Optimal diagnosis and treatment strategies for LC are: 1) screening and early detection of LC; 2) availability of experienced thoracic surgeons because of complexity of radical procedures; 3) aggressive en block surgery and adequate lymph node dissection for completeness; 4) precise prediction; 5) adjuvant chemoimmunoradiotherapy for LCP with unfavorable prognosis.
Explore natural remedies for syphilis treatment in Singapore. Discover alternative therapies, herbal remedies, and lifestyle changes that may complement conventional treatments. Learn about holistic approaches to managing syphilis symptoms and supporting overall health.
Couples presenting to the infertility clinic- Do they really have infertility...Sujoy Dasgupta
Dr Sujoy Dasgupta presented the study on "Couples presenting to the infertility clinic- Do they really have infertility? – The unexplored stories of non-consummation" in the 13th Congress of the Asia Pacific Initiative on Reproduction (ASPIRE 2024) at Manila on 24 May, 2024.
Knee anatomy and clinical tests 2024.pdfvimalpl1234
This includes all relevant anatomy and clinical tests compiled from standard textbooks, Campbell,netter etc..It is comprehensive and best suited for orthopaedicians and orthopaedic residents.
Title: Sense of Smell
Presenter: Dr. Faiza, Assistant Professor of Physiology
Qualifications:
MBBS (Best Graduate, AIMC Lahore)
FCPS Physiology
ICMT, CHPE, DHPE (STMU)
MPH (GC University, Faisalabad)
MBA (Virtual University of Pakistan)
Learning Objectives:
Describe the primary categories of smells and the concept of odor blindness.
Explain the structure and location of the olfactory membrane and mucosa, including the types and roles of cells involved in olfaction.
Describe the pathway and mechanisms of olfactory signal transmission from the olfactory receptors to the brain.
Illustrate the biochemical cascade triggered by odorant binding to olfactory receptors, including the role of G-proteins and second messengers in generating an action potential.
Identify different types of olfactory disorders such as anosmia, hyposmia, hyperosmia, and dysosmia, including their potential causes.
Key Topics:
Olfactory Genes:
3% of the human genome accounts for olfactory genes.
400 genes for odorant receptors.
Olfactory Membrane:
Located in the superior part of the nasal cavity.
Medially: Folds downward along the superior septum.
Laterally: Folds over the superior turbinate and upper surface of the middle turbinate.
Total surface area: 5-10 square centimeters.
Olfactory Mucosa:
Olfactory Cells: Bipolar nerve cells derived from the CNS (100 million), with 4-25 olfactory cilia per cell.
Sustentacular Cells: Produce mucus and maintain ionic and molecular environment.
Basal Cells: Replace worn-out olfactory cells with an average lifespan of 1-2 months.
Bowman’s Gland: Secretes mucus.
Stimulation of Olfactory Cells:
Odorant dissolves in mucus and attaches to receptors on olfactory cilia.
Involves a cascade effect through G-proteins and second messengers, leading to depolarization and action potential generation in the olfactory nerve.
Quality of a Good Odorant:
Small (3-20 Carbon atoms), volatile, water-soluble, and lipid-soluble.
Facilitated by odorant-binding proteins in mucus.
Membrane Potential and Action Potential:
Resting membrane potential: -55mV.
Action potential frequency in the olfactory nerve increases with odorant strength.
Adaptation Towards the Sense of Smell:
Rapid adaptation within the first second, with further slow adaptation.
Psychological adaptation greater than receptor adaptation, involving feedback inhibition from the central nervous system.
Primary Sensations of Smell:
Camphoraceous, Musky, Floral, Pepperminty, Ethereal, Pungent, Putrid.
Odor Detection Threshold:
Examples: Hydrogen sulfide (0.0005 ppm), Methyl-mercaptan (0.002 ppm).
Some toxic substances are odorless at lethal concentrations.
Characteristics of Smell:
Odor blindness for single substances due to lack of appropriate receptor protein.
Behavioral and emotional influences of smell.
Transmission of Olfactory Signals:
From olfactory cells to glomeruli in the olfactory bulb, involving lateral inhibition.
Primitive, less old, and new olfactory systems with different path
263778731218 Abortion Clinic /Pills In Harare ,sisternakatoto
263778731218 Abortion Clinic /Pills In Harare ,ABORTION WOMEN’S CLINIC +27730423979 IN women clinic we believe that every woman should be able to make choices in her pregnancy. Our job is to provide compassionate care, safety,affordable and confidential services. That’s why we have won the trust from all generations of women all over the world. we use non surgical method(Abortion pills) to terminate…Dr.LISA +27730423979women Clinic is committed to providing the highest quality of obstetrical and gynecological care to women of all ages. Our dedicated staff aim to treat each patient and her health concerns with compassion and respect.Our dedicated group ABORTION WOMEN’S CLINIC +27730423979 IN women clinic we believe that every woman should be able to make choices in her pregnancy. Our job is to provide compassionate care, safety,affordable and confidential services. That’s why we have won the trust from all generations of women all over the world. we use non surgical method(Abortion pills) to terminate…Dr.LISA +27730423979women Clinic is committed to providing the highest quality of obstetrical and gynecological care to women of all ages. Our dedicated staff aim to treat each patient and her health concerns with compassion and respect.Our dedicated group of receptionists, nurses, and physicians have worked together as a teamof receptionists, nurses, and physicians have worked together as a team wwww.lisywomensclinic.co.za/
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists Saeid Safari
Preoperative Management of Patients on GLP-1 Receptor Agonists like Ozempic and Semiglutide
ASA GUIDELINE
NYSORA Guideline
2 Case Reports of Gastric Ultrasound
Ethanol (CH3CH2OH), or beverage alcohol, is a two-carbon alcohol
that is rapidly distributed in the body and brain. Ethanol alters many
neurochemical systems and has rewarding and addictive properties. It
is the oldest recreational drug and likely contributes to more morbidity,
mortality, and public health costs than all illicit drugs combined. The
5th edition of the Diagnostic and Statistical Manual of Mental Disorders
(DSM-5) integrates alcohol abuse and alcohol dependence into a single
disorder called alcohol use disorder (AUD), with mild, moderate,
and severe subclassifications (American Psychiatric Association, 2013).
In the DSM-5, all types of substance abuse and dependence have been
combined into a single substance use disorder (SUD) on a continuum
from mild to severe. A diagnosis of AUD requires that at least two of
the 11 DSM-5 behaviors be present within a 12-month period (mild
AUD: 2–3 criteria; moderate AUD: 4–5 criteria; severe AUD: 6–11 criteria).
The four main behavioral effects of AUD are impaired control over
drinking, negative social consequences, risky use, and altered physiological
effects (tolerance, withdrawal). This chapter presents an overview
of the prevalence and harmful consequences of AUD in the U.S.,
the systemic nature of the disease, neurocircuitry and stages of AUD,
comorbidities, fetal alcohol spectrum disorders, genetic risk factors, and
pharmacotherapies for AUD.
Title: Sense of Taste
Presenter: Dr. Faiza, Assistant Professor of Physiology
Qualifications:
MBBS (Best Graduate, AIMC Lahore)
FCPS Physiology
ICMT, CHPE, DHPE (STMU)
MPH (GC University, Faisalabad)
MBA (Virtual University of Pakistan)
Learning Objectives:
Describe the structure and function of taste buds.
Describe the relationship between the taste threshold and taste index of common substances.
Explain the chemical basis and signal transduction of taste perception for each type of primary taste sensation.
Recognize different abnormalities of taste perception and their causes.
Key Topics:
Significance of Taste Sensation:
Differentiation between pleasant and harmful food
Influence on behavior
Selection of food based on metabolic needs
Receptors of Taste:
Taste buds on the tongue
Influence of sense of smell, texture of food, and pain stimulation (e.g., by pepper)
Primary and Secondary Taste Sensations:
Primary taste sensations: Sweet, Sour, Salty, Bitter, Umami
Chemical basis and signal transduction mechanisms for each taste
Taste Threshold and Index:
Taste threshold values for Sweet (sucrose), Salty (NaCl), Sour (HCl), and Bitter (Quinine)
Taste index relationship: Inversely proportional to taste threshold
Taste Blindness:
Inability to taste certain substances, particularly thiourea compounds
Example: Phenylthiocarbamide
Structure and Function of Taste Buds:
Composition: Epithelial cells, Sustentacular/Supporting cells, Taste cells, Basal cells
Features: Taste pores, Taste hairs/microvilli, and Taste nerve fibers
Location of Taste Buds:
Found in papillae of the tongue (Fungiform, Circumvallate, Foliate)
Also present on the palate, tonsillar pillars, epiglottis, and proximal esophagus
Mechanism of Taste Stimulation:
Interaction of taste substances with receptors on microvilli
Signal transduction pathways for Umami, Sweet, Bitter, Sour, and Salty tastes
Taste Sensitivity and Adaptation:
Decrease in sensitivity with age
Rapid adaptation of taste sensation
Role of Saliva in Taste:
Dissolution of tastants to reach receptors
Washing away the stimulus
Taste Preferences and Aversions:
Mechanisms behind taste preference and aversion
Influence of receptors and neural pathways
Impact of Sensory Nerve Damage:
Degeneration of taste buds if the sensory nerve fiber is cut
Abnormalities of Taste Detection:
Conditions: Ageusia, Hypogeusia, Dysgeusia (parageusia)
Causes: Nerve damage, neurological disorders, infections, poor oral hygiene, adverse drug effects, deficiencies, aging, tobacco use, altered neurotransmitter levels
Neurotransmitters and Taste Threshold:
Effects of serotonin (5-HT) and norepinephrine (NE) on taste sensitivity
Supertasters:
25% of the population with heightened sensitivity to taste, especially bitterness
Increased number of fungiform papillae
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?bkling
Are you curious about what’s new in cervical cancer research or unsure what the findings mean? Join Dr. Emily Ko, a gynecologic oncologist at Penn Medicine, to learn about the latest updates from the Society of Gynecologic Oncology (SGO) 2024 Annual Meeting on Women’s Cancer. Dr. Ko will discuss what the research presented at the conference means for you and answer your questions about the new developments.
New Drug Discovery and Development .....NEHA GUPTA
The "New Drug Discovery and Development" process involves the identification, design, testing, and manufacturing of novel pharmaceutical compounds with the aim of introducing new and improved treatments for various medical conditions. This comprehensive endeavor encompasses various stages, including target identification, preclinical studies, clinical trials, regulatory approval, and post-market surveillance. It involves multidisciplinary collaboration among scientists, researchers, clinicians, regulatory experts, and pharmaceutical companies to bring innovative therapies to market and address unmet medical needs.
- Video recording of this lecture in English language: https://youtu.be/lK81BzxMqdo
- Video recording of this lecture in Arabic language: https://youtu.be/Ve4P0COk9OI
- Link to download the book free: https://nephrotube.blogspot.com/p/nephrotube-nephrology-books.html
- Link to NephroTube website: www.NephroTube.com
- Link to NephroTube social media accounts: https://nephrotube.blogspot.com/p/join-nephrotube-on-social-media.html
COMPUTER AIDED FORMULATION DESIGN EXPERT SOFTWARE CASE STUDY
1. Computer aided formulation development
Roshan Bodhe PH-02 Page 1
INTRODUCTION TO COMPUTER AIDED FORMULATION AND DEVOLOPMENT:
Formulation and development is a process of selection of component and processing.Now days
computer tools used in the formulation and development of pharmaceutical product.Various
technique such as design of experiment are implemented for optimization of formulation and
processing parameter.Traditionally optimization in pharmaceuticals refer changing one variable
at a one time, so to obtain solution of a problematic formulation.Many times finding the correct
answer is not simple and straight forward in such cases use of computer tools (optimization
procedure) for best compromise is the smarter way to solve problem.
OPTIMIZATION TERM:-
Optimization means:-
Optimization means choosing the best element from some set of available alternatives.
To optimize means, to make as perfect as possible, to make as functional as possible, to
make as effective as possible, so as possible is important then optimization means what
1. Perfect by whose method?
2. For what characteristics?
3. For what condition?
Factor: -It is an assigned & independent variables, Such as temperature and
concentration. Those are quantitative & qualitative.
Level:-Those are designation assigned to the factor. Level indicated as high, low,
medium,Eg:-polymer ratios.
Response:-It is an outcome of an experiment. Eg:- Disintegration time
Response surface:-Response surface representing a relationship between the
independent variables X1&X2 and dependent variables Y.
OPTIMIZATION IS OPTIONAL THING OR NOT:-
Before you submit the application for the approval they make inspection of your provision and
facilities known as pre approval provision.Sodue to this approach optimization is not a optional
thing. In earlier days approvalwas given first then they conduct the inspection.Now the things are
change. There is provision known as pre- approval inspection,before they grant the approval they
will inspect the
1)Inspect the facilities.
2)Inspect and check the formulation.
Why this additives is there?
Why this excipient added in to this concentration?
Why the weight of tablet?
So, due to this each and every thing you will justify and defend masterformula record and batch
manufacturing records.so you have justify your formulation justify your formulation.
2. Computer aided formulation development
Roshan Bodhe PH-02 Page 2
For Example: - Why you are heating at 60 degree not on 90 degree.Why you are adding this
preservative or antimicrobial agent to this concentration.So it is notoptional thing, we cannot
escape this, because optimization is mandatory and regulatory need of formulation and
development of pharmaceutical product.
REGULATORY NEED OF OPTIMIZATION TECHNIQUE:
Optimization is a regulatory or mandatory thing required during the formulation and
development because of following reason.Provide in depth understanding to explore and further
defend in the formulation development.
So it is also benefit of manufacturing of formulation. Because you know each and every detail
and probably it’s his expansion and review and all things will be in his hand. So, optimization is
not screening technique,but it is regulatory thing.
OPTIMIZATION IS A TRIAL AND METHOD:-
Early optimization is done on the basis of trial and error method.
What is mean by trial and error?
A series oflogical steps carefully controlling the variables and changing one variable at a time till
satisfactory result produced. So gross variables carefully understood by changing one variable at
atime and making a small change in to it then series ofthis experiment has been done.
If the experiment is done with sufficient length of time, at adequate resources, sufficient time and
help, then time will come and he will come with perfect product.
Golden principles required during the formulation and development because in pharmaceutical
field,those principles decide the things regarding for formulation and development. Because in
pharmaceutical industry you may have thousands of chemical and excipient available,then you
should put more and more quantity.
1) Minimum and absolute quantity of ingredient in formulation:-
Those related to quantity and number of excipient in the formulation. Because we added more
and more ingredient,then those putting burden on labor, and process of manufacturing.
2) Minimum number of steps:-
More will be the unit process then more will be the energy is consumed, more will be the
parameter required at each step.So minimum and absolutely small no. of unit operation required
during formulation and development.
OPTIMIZATION PARAMETER:-
A) Problem types:-
There are two types of problem which are usually addressed in the optimization technique.
a) Unconstrain problem:-
In unconstrain there is no restriction place on the system, then that called as unconstrain
problem.
3. Computer aided formulation development
Roshan Bodhe PH-02 Page 3
In pharmaceutics unconstrain problem are not exist.
Example:- Make the hardest tablet as possible.
2)Constrain problem:-In that some restriction place on the system,
Those problem are important in the pharmaceutical so we think about the constrain
problem.
Example: -Make the hardest tablet as possible, but it disintegrate within 15 min.
Variables types:-
There are certain variables in optimization technique regarding the pharmaceutical
formulation.
These are the measurement values, whichare characteristics of data that called veriables.
There are two types of variables, are as fallow.
a) Dependent variables
b) Independent variables
1) Independent variables in optimization technique:-
That means things you can operate on your own choice,called as independent
variables
These variables under the control of formulator.E.g Mixing time,Concentration of
binder,Drug to polymer ratio,Compression force. These does not depend upon any
other values.
2) Dependent variables:-
These are variables which are not directly under the control of formulator. These
variables are response or chartecteristics of independent variables
VARIOUS EXPERIMENTAL DESIGN
1. Completely randomized designs
2. Randomized block designs
3. Factorial designs
4. Full Fractional Response surface designs
5. Central composite designs
6. Box-Behnken designs
7. Adding center points
8. Three level full factorial designs
1. Completely randomized Designs:-
Theseexperiment compares the values of are response variable based anddifferent
levels of that primary factor.
For example:- if there are 3levels of the primary factor with each level to be run 2
times then there are 6 factorial possible run sequences.
2. Randomized block designs
4. Computer aided formulation development
Roshan Bodhe PH-02 Page 4
For this there is one factor or variable that is of primary interest. To control non-
significant factors, an important technique called blocking can be used to reduce or
eliminate the contribution of these factors to experimental error.
3. Factorial design:-Full Used for small set of factors.
4. Fractional:-It is used to examine multiple factors efficiently with fewer runs
than corresponding full factorial design.
TYPES OF FRACTIONAL FACTORIAL DESIGNS:
1. Homogenous fractional
2. Mixed level fractional
3. Box-Hunter
4. Plackett-Burman
5. Taguchi Latin square
Homogenous fractional:-
Useful when large number of factors must be screened.
Design of Experiment For Formulation And Development:
All pharmaceutical products are formulated to specific dosage form drugs to be effectively
delivered to patient typical pharmaceutical dosage form include tablets, capsules, solution
suspension, etc
Different dosage form required different technology usually present different technological
challenge for formulation & development .Due to complex challenges, formulations scientist
used effective methodology like as design of experiment and statistical analysis for formulation
and development .
Formulation scientist used this method for process optimization and process validation .
EXPERIMENTAL DESIGN:-
The designs used for simultaneous methods are frequently referred to as response surface
designs. Various experimental designs frequently involved in the execution of RSM can broadly
classified as:
A. Factorial design and modifications
B .Central Composite design and modifications
C .Mixture designs
D .D-optimal designs
A. Factorial design and modifications :-
Factorial designs (FDs; full or fractional) are the most frequently used response surface designs.
These are generally based upon first-degree mathematical models. Full FDs involve studying the
effect of all the factors (n) at various levels (x), including the interactions amongst them, with the
total number of experiments as xn. The simplest FD involves study of two factors at two levels,
with each level coded suitably.
FDs are said to be symmetric, if each factor has same number of levels, and asymmetric, if the
number of levels differs for each factor.
5. Computer aided formulation development
Roshan Bodhe PH-02 Page 5
Besides RSM, the design is also used for screening of influential variables and factor influence
studies. Representsa 22 and 23 FD pictorially, where each point represents and individual
experiment.The mathematical model associated with the design consists of the main effects of
each variable plus all the possible interaction effects, i.e., interactions between the two variables,
and in fact, between as many factors as are there in the model.
The mathematical model generally postulated for FDs is given as
Y = b0 + b1X1... + b12X1X2... + b123X1X2X3... + e …
where,
bi, bij and e represent the coefficients of the variables and the interaction terms, and the random
experimental error, respectively. The effects (coefficients) in the model are estimated usually by
multiple linear regression analysis selection'. Their statistical significance is determined and then
a simplified model can be written
B Central composite design and its modifications:-
Also known as Box-Wilson design, it is the most often used design for second-order models ,
Central composite design (CCD) is comprised of the combination of a two-level factorial points
(2n),axial or star points (2n) and a central point.
Thus the total number of factor combinations in a CCD is given by 2n +2n + 1. The axial points
for a two-factor problem include, (± a, 0) and (0, ± a), where a is the distance of the axial points
from the center. A two factor CCD is identical to a 32 FD with square experimental domain .
a) face centered cube design (FCCD):-
Results when the same positive and negative distance is taken from the center in a CCD .
A rotatable is identical to FCCD except that the points defined for the star design are changed to
[± (2n )1/4,… 0] and those generated by the FD remain unchanged. In this way, the design
generates information equally well in all the directions.
e.g. the variance of the estimated response is same at all the points on a sphere centered at the
origin. The second-order polynomial for two factors, generally used for the composite designs.
b)Box-Behnken Design:-
Is a specially made design that requires only 3 levels (-1, 0, 1). It overcomes the inherent pitfalls
of CCD, where each factor has to be studied at 5 levels (except for 2 factors with a = ± 1, where
the number of levels per factor is 3), thus the number of experiments increases with rise in the
number of factors.
A BBD is an economical alternative to CCD. Also called as orthogonal balanced incomplete
block design, these are available for 3 to 10 factors. Because the design involves study at three
levels, the quadratic model is considered to be most appropriate.
C ) Mixture designs:-
In FDs and the CCDs, all the factors under consideration can simultaneously be varied and
evaluated at all the levels. This may not be possible under many situations. Particularly, in
pharmaceutical formulations with multiple excipients, the characteristics of the finished product
usually depend not so much on the quantity of each substance present but on their proportions.
Here, the sum total of the proportions of all excipients is unity and none of the fractions can be
negative.
Therefore, the levels of the various components can be varied with the restriction that the sum
total should not exceed one. Mixture designs are highly recommended in such cases. In a two-
component mixture, only one factor level can be independently varied, while in a three-
component mixture only two factor levels, and so on. The remaining factor level is chosen to
6. Computer aided formulation development
Roshan Bodhe PH-02 Page 6
complete the sum to one. Hence, they have often been described as experimental designs for the
formulation optimization. For process optimization, however, the designs like FDs and CCDs
are preferred.There are several types of mixture designs, the most popular being the simplex
design.
Scheffé s polynomial equation:-
components are given as under:
Linear : Y = b1X1 + b2X2 + b3X3 … (
Quadratic : Y = b1X1 + b2X2 + b3X3 + b12X1X2 + b13X1X3 + b23X2X3 ...
Special cubic model: Y = b1X1 + b2X2 + b3X3 + b12X1X2 + b13X1X3 + b23X2X3 +
b123X1X2X3 …
The mathematical model of mixture designs does not have the intercept in its equations. As a
consequence,these Scheffé models are not calculated by linear regression.
D) D-optimal designs:
If the experimental domain is of a definite shape, e.g., cubic or spherical, the standard
experimental designs are normally used. However, in case the domain is irregular in shape, D-
optimal designs can be used.
These are non-classical experimental designs based on the D-optimum criterion, and on the
principle of minimization of variance and covariance of parameters. The optimal design method
requires that a correct model is postulated, the variable space defined and the number of design
points fixed in such a way that will determine the model coefficients with maximum possible
efficiency.
One of the ways of obtaining such a design is by the use of exchange algorithms using
computers. These designs can be continuous, i.e., more design points can be added to it
subsequently, and the experimentation can be carried out in stages. D-optimal designs are also
used for screening of factors
Depending upon the problem, these designs can also be used along with factorial, central
composite and mixture designs.
COMPUTER SOFTWARE USED IN THE FORMULATION AND
DEVELOPMENT:-
Choice of Computer Software Package:-
Many commercial software packages are also available, which are either dedicated to a set of
experimental designs or are of a more general statistical nature with modules for select
experimental design(s). The dedicated computer software is frequently better as the user pays
only for the DoE capabilities. In contrast, the more powerful, comprehensive and expensive
statistical packages like SPSS, SAS, BBN, BMDP, MINITAB, etc. are geared up for larger
enterprises offering diverse facilities for statistical computing, support for networking and client-
server communication, and portability with a variety of computer hardware. When selecting a
DoE software, it is important to look for not only a statistical engine that is fast and accurate but
also the following:
• A simple graphic user interface (GUI) that's intuitive and easy-to-use.
• A well-written manual with tutorials to get you off to a quick start.
• A wide selection of designs for screening and optimizing processes or product formulations.
• A spreadsheet flexible enough for data entry as well as dealing with missing data and changed
factor levels.
7. Computer aided formulation development
Roshan Bodhe PH-02 Page 7
• Graphic tools displaying the rotatable 3-D response surfaces, 2-D contour plots, interaction
plots and the plots revealing model diagnostics
• Software that randomizes the order of experimental runs. Randomization is crucial because it
ensures that "noisy" factors will spread randomly across all control factors.
• Design evaluation tools that will reveal aliases and other potential pitfalls.
• After-sales technical support, online help and training offered by manufacturing vendors
Software Salient feature Source
Design Expert Powerful, comprehensive and
popular package used for
optimizing pharmaceutical
formulations and processes;
allows screening and study of
influential variables for FD,
FFD, BBD,CCD, PBD and
mixture designs; provides 3D
plots that can be rotated to
visualize the response surfaces
and 2D contour maps;
numerical and graphical
optimization
www.statease.com
MINITAB Powerful DoE software for
automated data analysis,
graphic and help features, MS-
Excel compatibility, includes
almost all designs of RSM
www.minitab.com
JMP DoE software for automated
data analysis of various
designs of RSM, graphic and
help features
www.jmp.com
CARD Powerful DoE software for
automated data analysis,
includes graphic and help
features
www.s-matrix.com
DoE PRO XL &
DoE KISS
MS-Excel compatible DoE
software for automated data
analysis using Taguchi, FD,
FFD and PBD. The relatively
inexpensive software, DoE
KISS is, however, applicable
only to single response
variable.
www.sigmazone.com
MATREX Excel compatible optimization
software with facilities for
various experimental designs
http://www.rsd-
associates.com/
matrex.htm
8. Computer aided formulation development
Roshan Bodhe PH-02 Page 8
HOW TO USED DESIGN EXPERT SOFTWARE VERSION 7.0
How to install design expert software
1) Install the exe file
2) Do not run design expert now
3) Copy the crack from crack folder to C/ program file / DX 7 trail run
4) If you want help then press F1for help
SOP OF DESIGN EXPERT SOFTWARE :-
1) File new design
2) Click response surface
3) Add numeric factor
4) write name of independent variables
5) Add low limit and high limit
6) Continue
7) Add response
8) Run will be generated
APPLYING DESING OF EXPERIMENT:-
DOE is an important tool for formulation scientist,Because those gives intelligent and important
decision at every stage of formulation and development. For example, In the formulation of
tablet consist different excipient ,And those affected on final formulation.
Factor Low level (mg) High level (mg) Effect on
Diluent ratio 10 15 Disintegration time
Disintegration level 5 10 Dissolution time
Binder level 4 6 Friability
Lubricant level 6 8 Weight uniformity
Major Technical Challenges in Tablet Formulation Development & Role of DOE:-
Major challenge Potential process Technologies
Uniformity Fluid Bed Granulation
Compatibility Highly Compressible excipient
Flow ability Free Flowing excipients
Dissolution Tablet Matrix containing polymer
and Taguchi design.
9. Computer aided formulation development
Roshan Bodhe PH-02 Page 9
STEP IN FORMULATION AND DEVELOPMENT
1) Excipient compability:-
i. First step in formulation and development is campactability study those select the
excipient.
ii. Those are physically and chemically compatible with the API
iii. It should be biodegradable and compatible
iv. By applying doe we can understand interaction effect with API over a time.
v. By applying DOE we can understand the interaction effect of excipient with API.
Feasibility Study:
i. Excipients are selected from excipient compability study, and next step is the feasibility
study.
i. Those conducted to determine the manufacturing process that enable the formulation to
achieve TPP
ii. Those evaluated technical challenges associated with the formulation and development
iii. In table no. 1 potential process are given to overcome the challenges in formulation and
development.
iv. As technical challenges overcome the next step is selection of manufacturing process.
Selection Of Manufacturing Process:
1) Formulation preliminary study:-
Those gives idea about selection of final excipient
2) Formulation optimization study:-
Those define the optimum level of excipient in the each formulation.
During this many formulation factor and response are evaluated in tablet formulation and
development. table 3
These problems can be solve by applying doe.
Those gives idea to understand formulation system and optimize the formulation by
choosing best combination of excipient to achieve the TPP
Initial Formulation System for Tablet Formulation
FACTOR API LEVEL & EXCIPIENT CHOICE
API 5-10%
DILUENT MICROCRYSTALINE CELLULOSE
STARCH, LACTOSE
DISINTEGRANT SODIUM STARCH GLYCOLATE
LUBRICANT MAGNECIUM STEARATE
Design and Conduct a Formulation Optimization Study
10. Computer aided formulation development
Roshan Bodhe PH-02 Page 10
FACTOR EXCIPIENT LOW STRENGTH
( % )
HIGHSTRENGTH
(%)
API - 5 10
Diluent MCC 59 30
Disintegrant Crospovidone 5 5
lubricant Magnesium
stearate
1 1
VARIOUS VARIABLES:-
VARIABLES NO. OF LEVELS
API% 2
DILUENT 3
DISINTEGRANT 2
LUBRICANT 2
CASE STUDY
Experimentaldesign manufacturing of Atenolol tablet:-
Atenolol, heavy magnesium carbonate, maize starch and sodium lauryl sulphate , were mixed in
Rapid Mixer Granulator and pneumatics, for 10 mins at different impeller and chopper speed.
Purified water (50%) was heat and add gelatin in heated water withconstant stirring until
dissolve. 3.57 % w/w maize starch paste (granulating agent) was prepared with boiling purified
water. Add the gelatin solution to starch paste and mixed properly. Add the granulatingagent to
the material over a period of 2 min at different impeller and chopper speed followed by kneading
for about 2 min to get a good granular mass. Wet granular mass was dried in fluidized bed dryer ,
at an internal temperature of 60 ± 5°C, outlet temperature 40±5°C till a loss on drying of 1.5.3.3
% was achieved on IR moisture balance in auto mode at 105°C.
Dried granules were sifted through 18 mesh on vibratory sifter and mill the retentions of granules
through 1 mm screen of multimill , with knives forward direction at slow speed. The dried
granules were blended with 1% magnesium stearate in Octagonal.
In the presented study, granulation process wasoptimized by taking three different lots, in which
dependent variables were impeller speed, binder addition time, chopper speed, impeller mixing
timeblender for 20 min. Tablets (390mg) were compressed on a 16 station rotary tablet
compression machine using a 9 mm standard flat-face punch.
The prepared tablets were round and flat with an average diameter of 9.0 ± 0.1 mm and a
thickness of 4.75 ± 0.2 mm. and their effect on bulk density, true density, Carr.s index, and
hausner ratio.
11. Computer aided formulation development
Roshan Bodhe PH-02 Page 11
Table 1 Presentation of 3 experiments with variables for granulation process:-
Lot no Impeller
Speed
Binder
addition
time(min)
Impeller
mixing
time(min)
AMP.
Reading
Chopper
Speed
1 Fast 1 12 3.7 Slow
2 Slow 2 8 3.9 Fast
3 Fast 2 6 3.9 Fast
Table3.CompressionprocessvariablesdesignandResponsedataofbatchesintheBoxBehnkend
esign
Batch X1(Ton) X2
(ton)
X3(rpm) Hardness(N) Friability (%) DT(sec)
BB1 -1 -1 0 28.34 1.8 122
BB2 -1 -1 0 57.7 0.3 362
BB3 -1 -1 0 35.39 0.2 128
BB4 -1 -1 0 70.30 0.8 96
BB5 0 0 -1 42.66 0.8 215
BB6 -1 0 -1 59.09 0.23 303
Variables
Level
Low(-1) Medium(0) High (1)
X1
(Precompression
Force)
0 1 2
X2
(Compression Force)
2 4 6
X3
(Compression Speed)
25 30 35
For compression process three levels Factorial Box- Behnken experimental design was used to
evaluateeffect of selected independent variables on the responses, to characterize physical
properties oftablets and to optimize the procedure. This design is suitable for exploration of
quadratic response surfaceand for construction of polynomial models, thus helping to optimize
process by using a small numberof experimental runs. For the three levels three factor Box and
Behnken Experimental design, a total of 15 experimental runs, shown in Table 3, are needed.
The generated models contain Quadratic term explaining the non linear nature of responses This
design also resolves the three factor interaction effect of individual terms and allow a mid level
setting (0), for The design consists of replicated center points and a set of points lying at the mid
12. Computer aided formulation development
Roshan Bodhe PH-02 Page 12
points of each edge of multidimensional cube that defines the region ofinterest .The model is of
the following form:
y = b0 + b1x1 +b2x2 +b3x3 +b4x1x2 +b5x2x3+b6x1x3 +b7x12+b8x22+b9x32 + E
Where;
y is the selected response, b0-b9 are the regression coefficients, X1, X2 and X3 are the
factorsstudied and E is an error term. The Box-Behnken experimental design is an orthogonal
design.
Therefore, the factor levels are evenly spaced and coded for low, medium and high settings; as -
1, 0, +1 Factors studied in the Box and Behnken experimental design where precompression
force (X1), compression force (X2) and compression speed(X3). The factors levels are shown in
Table 3. The selected responses were Hardness (Y1), friability (Y2)and Disintegration time (Y3).
The responses studied and the constraints selected considering AtenololPhysical properties and
regarding U.S.FDA guidelines, presented in Table 4.
Table 4: Responses selected and the constraints used in Box-Behnken design
Code Parameter Constraints
Y1 Hardness 30-40 N
Y2 Friability NMT 0.5 % W/w
Y3 Disintegration time NMT 10 min
EVALUATION OF TABLETS:-
1. Hardness:-
The hardness of the tablets was tested for 10 tablets by pharma hardness teste and average
hardness (N) was being taken and compared with that of standard one.
2. Friability :-
Friability test was performed in accordance with USP , 5 tablets wereselected randomly, their
individual weight was taken and then kept in the friabilator and rotated for 4 minat a speed of 25
rpm the tablets were taken out and any loose dust from them was removed, the weightwas
registered and friability was calculated as a percentage weight loss.
3. Disintegration time :-
The disintegration of the tablets was tested in a disintegration tester , sixtablets were put in to a
basket that was raised and lowered in a beaker containing preheated water at37 °C. The
disintegration test was calculated as the mean value and as the range.
4. In-vitro dissolution studies :-
The release rate of atenolol from tablets (n=3) was determined according to British
Pharmacopoeia (ref)using the Dissolution Testing Apparatus 2 , fitted with paddles. The
13. Computer aided formulation development
Roshan Bodhe PH-02 Page 13
dissolution test was performed using 900 mL of 0.1 N HCl, 37±0.5°C and 50 rpm. A 5 ml
sample waswithdrawn from the dissolution apparatus at predetermine time interval, and the
samples werereplaced with fresh dissolution medium. The samples were filtered through a
0.45µm membrane filter and diluted to a suitable concentration with 0.1 N HCl. Absorbance of
these solution was measured at 275nm using UV/VIS spectrophotometer Cumulative drug
release was calculated usingthe equation generated from Beer Lamberts calibration curve in the
linearity range of µg/mL.
5. Statistical analysis
Statistical analysis of the Box-Behnken design batches was performed by multiple regression
analysis using Microsoft Excel. To evaluate the contribution of each factor with different levels
to theresponse, the two-way analysis of variance (ANOVA) was performed using the DESIGN
EXPERT 7.0.1, demo version software. To graphically demonstrate the influence of each factor
on theresponse, the response surface plots were generated using DESIGN EXPERT 7.0.1
(STAT-EASE) demoversion software.
RESULTS AND DISCUSSION :-
In the present investigation, combinations of three variables were studied using the Box-
Behnkenexperimental design. The mathematical models developed for all the dependent
variables usingstatistical analysis software are shown in equations (1)-(3):
Hardness = 48.43 + 11.92 X1 + 5.60 X2 - 0.37 X3 + 1.38 X1 X2 - 0.58 X1 X3 + 2.19 X2 X3 -
1.41 X12+ 0.91 X22 - 5.10 X32 R2 0.6794 ------ (1)
Friability = 0.90-0.45 X1 - 0.19 X2 + 0.13 X3 + 0.19 X1X2 - 0.43 X1 X3 - 0.17 X2 X3 + 0.016
X12 - 0.16 X22 .
0.21 X32 R2= 0.8202 ------ (2)
Disintegration Time = 262.00 + 62.25 X1 + 53.25 X2 + 85.25 X3 - 68.00 X1 X2 + 28.50 X1X3
+ 168.50X2
X3 - 72.75 X12 - 12.25 X22 + 59.75 X32 R2 = 0.6043 ------- (3)
The hardness of all tablets was found to be below 61 N
Table 5: Box-Behnken Experimental Design
Batch X1(Ton) X2
(ton)
X3(rpm) Hardness(N) Friability (%) DT(sec)
BB1 -1 -1 0 28.35 1.5 122
BB2 -1 -1 0 57.52 0.2 362
BB3 -1 -1 0 35.39 0.5 128
BB4 -1 1 0 70.23 0.61 96
BB5 -1 0 -1 42.26 0.2 215
BB6 - 0 1 59.36 1.8 303
14. Computer aided formulation development
Roshan Bodhe PH-02 Page 14
Variables
Level
Low(-1) Medium(0) High (1)
X1
(Pre-compression
Force)
0 1 2
X2
(Compression Force)
2 4 6
Table 6: Analysis of variance for dependent variables from the Box-Behnken design
Sources SS DF MS F value Probability
Hardness
Regression 1526 9 169.56 1.18 0.0045
Residual 720.21 5 144.14
Total 2246.22 14
Friability
Regression 3.40 9 0.38 2.33 0.0015
Residual 0.74 5 0.15
Total 4.14 14
Disintegration
Regression 2.830 9 3.144 0.85 0.6097
Residual 1.853 5 3.700
Total 4.683 14 4.683
Table 7: Granulation Optimization : Analysis data
Lot No. Initial air
drying
time(min)
Total hot air
drying
time(min)
Inlet temp oC Out late temp
oC
LOD % w/w
1 10 50 50 44 1.50
2 10 60 60 44 1.80
3 10 70 55 38 2.20
Results and Discussion
In The Present investigation granulation and compression process were optimized.
Results and Discussion for Granulation:-
Batch No 1
15. Computer aided formulation development
Roshan Bodhe PH-02 Page 15
Process :-
In granulation process, impeller speed, binder addition time, chopper speed, impeller mixing
timewere studied by taking three different lots for dependent variables i.e. bulk density, true
density,Carr.s index, and hausner ratio (Table 2).
Effect of impeller and chopper speed
Various granulation batches prepared to study the effect of impeller and chopper speed are listed
intable 1
RESULTS AND DISCUSSION FOR COMPRESSION :-
Process:-
Combinations of three independent variables werestudied using t he Box Behnken design.
Themathematical models developed for all the dependent variables using design expert software
areshown in equation (1)-(3)
EFFECT OF PRE- COMPRESSION FORCE :-
Compression force and Compression speed :-
15 batches had been prepared to study the effect of pre compression force is listed in table no 3.
so, wetook three different pre compression force -1 indicates there is no pre compression force,0
indicates pre compression force is 1tonne,+1 indicates pre-compression force is 2 tonnes,after
preparing all the batches results showed that ,after applying pre compression force hardness
becomeshigher than limit in combination with lower compression force and lower compression
force showed cracking tableting defect (BB 4). So, result showed that Precompression force
should not begiven ,when we are applying higher compression force and ,and when Pre -
compression force is notgiven and compression force is also lowered cause lower hardness and
friability problems with highcompression speed.(BB 7) All three independent variables also
affects invitrodissolution studies ,if pre compression force is 2 tonnes and compression force 6
tonnes with lower compression speed 25 rpm ,takes more time to dissolve and vice versa.
Dissolution profiles for two Optimized batches BB 5 and BB 7 were analysed and compared
with innovator product and calculated for similarity factor showed result given in table no. 7
Table No 8
Formulation F2(Similarity Factor) F1 (Difference factor)
BB6 67 03
BB7 29 26
COMPARISION DATA USING DESIGN EXPERT SOFTWERE :-
17. Computer aided formulation development
Roshan Bodhe PH-02 Page 17
CONCLUSIONS:-
Design of experiment & statistical analysis have been used in the formulation
development
Using design of experiment formulation scientist evaluate the all formulation factors in
systematically and timely manner to optimize the formulation and manufacturing
process
When the pharmaceutical process and product are optimize by systematic approach then
process validation & scale up can be efficient because of the robustness of the
formulation and manufacturing process
18. Computer aided formulation development
Roshan Bodhe PH-02 Page 18
REFERENCES :-
1. Bolton S, Bon C. Pharmaceutical Statistics Practical & Clinical Application, 5TH ED.
New York London ;InformA Healthcare Publishing ; 2010.Pg No 239
2. JAIN N K “Pharmaceutical Product Development” ,CBS Publisher ; New Delhi2010.
Pp 295-340
3. Ganesh. R. Godage Advance Drug Delivery System, Tech Max Publication Pune 2017
Pp 6.1-6.24
4. Kubinyi H. Drug Research: Myths, Hype And Reality. Nature Reviews Drug Discovery.
2003 Aug;2(8):665.
5. Hussain As, Shivanand P, Johnson Rd. Application Of Neural Computing In
Pharmaceutical Product Development: Computer Aided Formulation Design. Drug
Development And Industrial Pharmacy. 1994 Jan 1;20(10):1739-52.